Enovis Free Cash Flow 2010-2024 | ENOV
Enovis free cash flow from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Enovis Annual Free Cash Flow | |
|---|---|
| 2023 | 45.34 |
| 2022 | -158.57 |
| 2021 | 258.90 |
| 2020 | 196.70 |
| 2019 | 13.33 |
| 2018 | 191.55 |
| 2017 | 171.23 |
| 2016 | 190.97 |
| 2015 | 233.94 |
| 2014 | 301.30 |
| 2013 | 290.69 |
| 2012 | 90.83 |
| 2011 | 43.53 |
| 2010 | 49.51 |
| 2009 | 27.92 |
| Enovis Quarterly Free Cash Flow | |
|---|---|
| 2024-09-30 | -102.35 |
| 2024-06-30 | -104.72 |
| 2024-03-31 | -73.08 |
| 2023-12-31 | 45.34 |
| 2023-09-30 | 14.87 |
| 2023-06-30 | -31.69 |
| 2023-03-31 | -22.99 |
| 2022-12-31 | -158.57 |
| 2022-09-30 | -85.83 |
| 2022-06-30 | -84.36 |
| 2022-03-31 | -35.77 |
| 2021-12-31 | 258.90 |
| 2021-09-30 | 189.20 |
| 2021-06-30 | 121.30 |
| 2021-03-31 | 59.85 |
| 2020-12-31 | 196.70 |
| 2020-09-30 | 96.48 |
| 2020-06-30 | 47.78 |
| 2020-03-31 | 26.80 |
| 2019-12-31 | 13.33 |
| 2019-09-30 | -27.16 |
| 2019-06-30 | -50.27 |
| 2019-03-31 | -95.36 |
| 2018-12-31 | 191.55 |
| 2018-09-30 | 78.32 |
| 2018-06-30 | 23.49 |
| 2018-03-31 | -4.72 |
| 2017-12-31 | 171.23 |
| 2017-09-30 | 94.04 |
| 2017-06-30 | 71.80 |
| 2017-03-31 | 28.70 |
| 2016-12-31 | 190.97 |
| 2016-09-30 | 60.18 |
| 2016-06-30 | 30.92 |
| 2016-03-31 | 0.13 |
| 2015-12-31 | 233.94 |
| 2015-09-30 | 119.41 |
| 2015-06-30 | 48.55 |
| 2015-03-31 | -13.21 |
| 2014-12-31 | 301.30 |
| 2014-09-30 | 142.47 |
| 2014-06-30 | -5.14 |
| 2014-03-31 | -79.63 |
| 2013-12-31 | 290.69 |
| 2013-09-30 | 135.93 |
| 2013-06-30 | 50.04 |
| 2013-03-31 | -31.39 |
| 2012-12-31 | 90.83 |
| 2012-09-30 | -49.30 |
| 2012-06-30 | -72.06 |
| 2012-03-31 | -128.18 |
| 2011-12-31 | 43.53 |
| 2011-09-30 | 30.96 |
| 2011-06-30 | 22.04 |
| 2011-03-31 | 1.68 |
| 2010-12-31 | 49.51 |
| 2010-09-30 | 26.02 |
| 2010-06-30 | 22.01 |
| 2010-03-31 | 13.60 |
| 2009-12-31 | 27.92 |
| 2009-09-30 | 26.46 |
| 2009-06-30 | 12.12 |
| 2009-03-31 | 7.58 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.671B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.870B | 55.80 |
| Tempus AI (TEM) | United States | $9.036B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $8.145B | 207.11 |
| Inspire Medical Systems (INSP) | United States | $5.799B | 180.84 |
| IRhythm Technologies (IRTC) | United States | $3.407B | 0.00 |
| Privia Health (PRVA) | United States | $2.742B | 228.50 |
| Azenta (AZTA) | United States | $2.470B | 131.83 |
| Clover Health Investments (CLOV) | United States | $2.200B | 0.00 |
| Omnicell (OMCL) | United States | $2.084B | 68.17 |
| Schrodinger (SDGR) | United States | $1.827B | 0.00 |
| 10x Genomics (TXG) | United States | $1.816B | 0.00 |
| Phreesia (PHR) | United States | $1.654B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.850B | 0.00 |
| Standard BioTools (LAB) | United States | $0.577B | 0.00 |
| Talkspace (TALK) | United States | $0.524B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.509B | 0.00 |
| TruBridge (TBRG) | United States | $0.370B | 107.91 |
| Nyxoah SA (NYXH) | Belgium | $0.368B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.343B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.229B | 0.00 |
| Pulmonx (LUNG) | United States | $0.224B | 0.00 |
| American Well (AMWL) | United States | $0.165B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.090B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.087B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.056B | 0.00 |
| 111 (YI) | China | $0.050B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.047B | 0.00 |
| Outset Medical (OM) | United States | $0.043B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.035B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.020B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |